Protagonist Therapeutics
PTGX
PTGX
274 hedge funds and large institutions have $3.15B invested in Protagonist Therapeutics in 2025 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 86 increasing their positions, 90 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 240 → 274 (+34)
0.29% more ownership
Funds ownership: 106.16% → 106.45% (+0.29%)
4% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 90
Holders
274
Holding in Top 10
14
Calls
$51.1M
Puts
$31.9M
Top Buyers
| 1 | +$96.7M | |
| 2 | +$35.4M | |
| 3 | +$32.6M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16.3M |
Top Sellers
| 1 | -$72.4M | |
| 2 | -$41.5M | |
| 3 | -$30.2M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$15.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$13.5M |
